July 7, 2008 – OLIGOMERIX, Inc. announced receipt of a program related investment of $100K from the Alzheimer's Drug Discovery Foundation (ADDF). The focus of the program is to select compounds using its proprietary Alzheimer’s disease (AD) screening assays active against tau oligomers, and to evaluate these compounds in a tauopathy mouse model... [PDF] OLIGOMERIX's Press Release -
Friday, July 11, 2008
OLIGOMERIX funded by the Alzheimer's Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic...
July 7, 2008 – OLIGOMERIX, Inc. announced receipt of a program related investment of $100K from the Alzheimer's Drug Discovery Foundation (ADDF). The focus of the program is to select compounds using its proprietary Alzheimer’s disease (AD) screening assays active against tau oligomers, and to evaluate these compounds in a tauopathy mouse model... [PDF] OLIGOMERIX's Press Release -
